the common disorders of asthma, atopic dermatitis and allergic rhinitis 1 . Chromosome 13q14 shows consistent linkage to atopy and the total serum IgE concentration 2-6 . We previously identified association between total serum IgE levels and a novel 13q14 microsatellite (USAT24G1; ref. 7) and have now localized the underlying quantitative-trait locus (QTL) in a comprehensive single-nucleotide polymorphism (SNP) map. We found replicated association to IgE levels that was attributed to several alleles in a single gene, PHF11. We also found association with these variants to severe clinical asthma. The gene product (PHF11) contains two PHD zinc fingers and probably regulates transcription. Distinctive splice variants were expressed in immune tissues and cells.
L E T T E R S
relationship to asthma 11 . We have consequently used it as a quantitative trait to map susceptibility genes for atopy and asthma. After confirming linkage of atopy and related phenotypes to chromosome 13q14 (refs. 2-6), we made a saturation map that indicated the locus associated with atopy was within a 7.5-cM region centering on D13S161 (ref. 12) . We found association between the total serum IgE and the microsatellite USAT24GI (ref. 7) . The limit of detection of linkage disequilibrium (LD) between a disease and a marker approximates a D′ of 0.33 (ref. 13 ). Approximately 80% of marker pairs at this locus showed a D′ < 0.33 by 100 kb 13 , suggesting that the gene associated with atopy was within 100 kb of USAT24G1.
We constructed a 1.5-Mb BAC and PAC contig centering on USAT24GI (ref. 7) . We then used scaffold sequence-tag sites (STSs) to prioritize genomic sequencing. We systematically identified expressed sequences by examination of expressed-sequence tag (EST) databases, by cDNA selection 7 and by 3′ and 5′ RACE.
We then constructed a dense SNP map around USAT24G1. We aimed to identify alleles with a minimum frequency of 0.15, because the variation underlying complex traits probably consists of common alleles that are evolutionarily old 14 , and rare alleles may require prohibitively large sample sizes to detect associations.
We identified 49 SNPs, 4 deletion-insertion polymorphisms and a (GGGC)n repeat with minor allele frequencies ≥15%. We genotyped these in a primary panel of 364 individuals in 80 nuclear families (AUS1). We carried out error checking and haplotype generation by MERLIN 15 . We measured D′ between markers from parental haplotypes 13 and depicted by GOLD 16 (Fig. 1a) .
We examined the evidence for association to the Log e (IgE concentration) (LnIgE) by variance components analyses 17 (Table 1) . Positive associations extended for approximately 100 kb in the A and Aii islands of LD (Table 1 and Fig. 1b) .
We tested three-, four-, and five-marker haplotypes for association in a sliding window across the locus. The results were not essentially different from the single-point associations (data not shown). We found no evidence of genetic admixture with any marker 17 . We obtained similar results using transmission tests of association, except that the expected reduction in power gave weaker significance levels.
The region of association to LnIgE centered on one gene (PHF11) and extended to two flanking genes (SETDB2 and RCBTB1; Table 1 and Fig. 1b) . We carried out a stepwise procedure in which the most significantly associated SNP was included as a covariate in the analysis using the QTDT program. We then repeated the analysis serially with the next most significantly associated remaining SNP included as an additional covariate until no significant associations remained. This analysis identified three SNPs as having independent effects (b5_2: χ 2 = 12.6, P = 0.0004; b4_2: remaining χ 2 = 7.13, P = 0.008; and b5_3: remaining χ 2 = 3.96, P = 0.05). These SNPs are within 8.1 kb of each other ( Table 1 ) and are found, respectively, in intron IX, intron V and the 3′ untranslated region of PHF11. Inclusion of SNPs in flanking genes as covariates did not abolish these associations.
We estimated the variation in the IgE levels from the locus attributable to genetic linkage as 11.5% (± 5.2% s.d.) by MERLIN. The variation attributable to association with the three SNPs measured by QTDT was 6.1%, suggesting the possible presence of other alleles contributing to linkage. Sequencing of cDNA from multiple subjects, however, identified no other SNPs. Our full coverage of the PHF11 complex suggests that if other alleles contribute to linkage, they must be located elsewhere within the 7.5-Mb linkage peak.
We typed six markers (b11_2, b4_2, b5_3, b43_1, b38_1 and b28_2) in other panels of subjects (AUS2, UK2 and ECZ). We assembled genotypes into three-marker haplotypes and carried out multi-allelic tests of association before examining individual haplotypes. The b4_2, b5_3, b43_1 haplotype showed consistent association to the LnIgE in each of the panels tested ( Table 2) . Two haplotypes containing the b4_2*2 and the b5_3*1 alleles (A and D; Table 2 ) showed negative association with the LnIgE, although they differed at b43_1. We observed positive association with the C haplotype (containing b4_2*1 and b5_3*2) in families with atopic dermatitis (ECZ). These results further localized the polymorphisms influencing IgE levels to b4_2 and b5_3.
The combined panel of Busselton families (AUS1 and AUS2) were recruited at random from the general Australian population 18 . We observed association to asthma in these subjects with the b4_2 and b5_3 markers (P = 0.024 and P = 0.017, respectively) using a transmission disequilibrium test 19 . In unrelated British adults, genotypes containing the b4_2*1 allele were significantly more common in severe asthmatics compared to non-atopic controls and were progressively less common in children with severe asthma and adults with mild asthma (P = 0.001 for trend; Table 3 ). We observed a similar pattern with b5_3. These results show relevance of the locus to severe clinical asthma.
LD mapping, therefore, consistently identified polymorphism in PHF11 as being responsible for variation in LnIgE. PHF11 encodes NY-REN-34, which was originally identified from patients with renal cell carcinoma 20 , and its transcripts are highly represented in stomach, tonsil and B cells.
The gene product contains two PHD (plant homeodomain) zinc fingers, which suggest involvement in chromatin-mediated transcriptional regulation 21 (Fig. 2) . PHD fingers normally posses two Zn 2+ coordinating groups that contain cysteine and histidine residues. The N-terminal (5′) finger of the PHF11 finger pair, however, lacks one of the two coordinating groups.
The arrangement of PHD fingers in PHF11 is characteristic of human proteins, such as ALL-1 and AF10, whose genes are fused in some cases of acute lymphoblastic leukemia 22 (Fig. 2) . Analogy to AF10 and ALL PHD fingers suggests that the PHF11 PHD finger pair probably has a role in homodimerization, protein binding or both.
The gene PHF11 contains 10 exons. Public databases identified an alternative first exon with multiple overlapping variants that produce alternative start methionines for protein translation. We were able to confirm these variants by sequencing specific PCR products from cDNA panels (data not shown).
PCR analysis of a segment of the gene from the orthodox first exon (exon I) to exon III showed a uniform distribution in cDNA from all tissues studied (Fig. 3a) . PCR products from the alternative first exon (exon Ia) were distributed in immune-related cells and tissues (Fig. 3a) . We observed multiple splice variants. Cloning and sequencing of these showed that exon Ia and II contain multiple splicedonor and -acceptor sequences. We commonly found cDNA variants that showed skipping of exon II in these PCR products and in the cDNA databases. Loss of exon II results in an incomplete first PHD domain. We also found variants that contained additional exons between exons V and VI (named exon Va and Vb). These variants differed by 54 bp and were only present in lung and peripheral blood leucocytes (PBL; Fig. 3a) . Examination of PBL fractions showed that the variants were present in unactivated CD4 + , CD8 + and CD19 + cells but were absent in activated cells. Exons Va and Vb both result in premature stop codons. Alternative splicing with a premature stop codon has been identified as a mechanism for negative control of transcription 23 , and a negative role for these variants is consistent with their expression in inactive T and B cells.
PHF11 is closely flanked by SETDB2 and RCBTB1. SETDB2 is 4 kb proximal to PHF11 and is transcribed in the same direction. It contains methyl-CpG-binding (MBD) and SET domains (Fig. 2) . The MBD seems to lack amino acids required to bind methylated CpG but retains the ability to bind unmethylated DNA. SET domains modulate gene expression epigenetically through histone H3 methylation 24, 25 . SETDB2 is probably a histone H3 methyltransferase, as it contains both active site and flanking cysteine residues that are important for catalytic activity 25 .
We identified two coding variants in SETDB2, an A→G conservative substitution in exon 7 leading to the amino acid change Q117G (d8ex7) and a G→A variant in exon 10 leading to the amino acid change V473M (d8ex10), which showed weak associations with LnIgE (P = 0.02 and P = 0.10, respectively; Table 1 ). These effects disappeared when polymorphism in PHF11 was taken into account.
The close genomic proximity of SETDB2 and PHF11 suggested that the two genes might be coordinately expressed or that a combined product, similar to IL-5 promoter REII region-binding protein, might be expressed (Fig. 2) . A northern blot for PHF11 showed high molecular weight bands that were most prominent in immune-related tissues (Fig. 3b) . We observed bands of similar size with SETDB2 (Fig. 3b) . PCR between exon XII of SETDB2 and exon III of PHF11 identified three variably expressed products (A, B and C) that contained different exons (Fig.  3c) . Sequence of a limited number of clones did not identify any extended open reading frames, but the presence of small variation of splice boundaries in exon II of PHF11 meant that we were not able to rule out an ORF in some transcripts.
RCBTB1 is only 3 kb 3′ of PHF11 but is transcribed in the opposite direction. It shows strong protein sequence similarity to RCC1 (regulator of chromatin condensation 1) and RLG (RCC1-like G exchanging factor). RCC1 binds to DNA and to histones H2A and H2B 26 . The close proximity of RCBTB1 to PHF11 and SETDB2 might suggest coregulation of all three genes.
QTLs in other organisms are characterized by variation in a number of clustered genes 27 . Although our genetic analysis indicates that variation in IgE levels at this locus is attributable to variation in PHF11, the coordinate regulation of PHF11 and SETDB2 and the possible presence of more distant alleles influencing linkage suggest that investigation of the function of the locus should include the three genes of this complex. We have previously shown linkage between this locus and the total serum concentration of immunoglobulins A, G and M. Testing the SNPs for association to these traits showed no evidence for association to IgA or IgG levels, but the total serum IgM concentration was associated with the b5_2 SNP (P = 0.004; variance = 3.6%). In contrast to serum IgE, high IgM levels accompanied the b5_2*2 rather than the b5_2*1 allele.
This narrow segment of chromosome 13q14 is within the minimum region commonly deleted in B-cell chronic lymphocytic leukemia 28 . Both PHF11 and SETDB2 show strong homologies with genes activated in multiple myeloma and leukemia, suggesting that B-cell clonal expansion and regulation of immunoglobulin expression may operate through shared mechanisms at this locus.
METHODS

Subjects.
We carried out primary mapping on 364 subjects in 80 nuclear families selected from a population sample of 230 families of European descent from the rural town of Busselton in Western Australia 3, 18 (the AUS1 panel). These families were selected to be informative for atopy. They all included both atopic and non-atopic members, and sibships of three or more were not exclusively atopic or non-atopic. The AUS2 panel consisted of the remaining 150 nuclear families from the population sample. The UK2 panel consisted of 87 nuclear families of British descent recruited when a child of the family attended an asthma clinic in the Oxford region. The families contained 216 offspring (148 sibling pairs). The ECZ panel consisted of 150 nuclear families predominately of European descent recruited from the dermatology clinics at the Great Ormond Street Hospital for Children, when one or more children of the family had active atopic dermatitis, as previously described 29 .
A case-control panel of British descent including 130 adults with severe asthma, 49 children with severe asthma and 92 individuals with mild asthma was recruited at the Royal Brompton Hospital, London, as previously described 30 . The mean age of the adults with severe asthma was 44.8 years, that of the children with severe asthma was 11.9 years and that of the individuals with mild asthma was 27.8 years. The ratio of the forced expiratory volume in 1 s to the forced vital capacity (FEV1/FVC) of the individuals with severe asthma was predicted to be <65%. We compared their genotypes to those of adults recruited by the blood transfusion service and designated them non-atopic with a total serum IgE concentration <100 IU l -1 .
All studies of subjects were approved by the Central Oxford Regional Ethics Committee and by the Human Rights Committee of the University of Western Australia. All subjects or their parents gave written informed consent to the study.
Phenotypes. The subjects were administered a standard respiratory questionnaire 18 . 'Asthma' was defined as a positive answer to the questions "Have you ever had an attack of asthma?" and "If yes, has this happened on more than one occasion?". We measured the total serum IgE by solid-phase immuno-assay (Pharmacia CAP system) and log e normalized the values before statistical analyses. Asthma in the case-control panel was diagnosed according to American Thoracic Society (ATS) criteria. Individuals with mild asthma suffered intermittent symptoms treated with infrequent (less than 2 times per week) short-acting β-agonists, did not use maintenance inhaled steroids and had normal lung function. Individuals with severe asthma had daily symptoms requiring regular inhaled β-agonist therapy and high-dose inhaled (at least 800 µg d -1 beclomethasone diproprionate or equivalent) or oral steroids and had impaired lung function.
SNP discovery and typing. We sequenced 10 diploid genomes (5 unrelated individuals with atopic disease and 5 unrelated control individuals) together with a pool of DNA from 32 unrelated individuals. This gave us 99.9% probability of detecting alleles with a minimal frequency of 0.2 and 99% probability of detecting alleles with a minimum frequency of 0.1 (ref. 31) . Dilution experiments with known alleles indicated that we were able to detect allele frequencies >0.15 with the pool. In addition, we sequenced all PHF11 exons in cDNA from 22 unrelated individuals, 12 of whom were atopic and 7 of whom were asthmatic. We extracted RNA using PAXgene blood RNA kit and subjected it to RT-PCR (QIAGEN OneStep RT-PCR) using two pairs of different primers for the alternate first exons that generated two major bands with or without exon II (primer sequences available on request). We sequenced 5-6 clones from the major bands using big dye labels. To control for Taq error, we screened for possible mutations in genomic DNA. This data, taken with the 9 complete cDNAs in the public databases, would have 99.9% probability of identifying SNPs with >0.1 frequency and 95% probability of identifying SNPs with >0.01 frequency 31 . Traces were assembled by the POLYPHRED/PHRAP programs. We genotyped SNPs by PCR and restriction digestion. In the absence of a natural restriction sequence, we modified a primer to generate a site. SNP primers are available on request.
Statistical analysis of association. We detected errors in SNP typing by testing for mendelian errors and by the MERLIN computer program 15 , which identifies improbable recombination events from dense SNP maps. We generated SNP haplotypes by MERLIN and recoded them as individual alleles.
We carried out tests of association to quantitative traits using the QTDT program, which allowed use of markers and phenotypes as covariates in analyses 17 . We examined association to asthma and categorical traits by the Monks test routine of QTDT in family samples 17, 19 and by exact tests of contingency tables in unrelated individuals with the StatXact program, version 4.0, reporting onesided P values.
Sequence analyses. We mapped STSs onto BAC contigs built by a combination of HindIII digest fingerprinting and STS content. We sequenced an overlapping set of clones from the RPCI-11 BAC library using a hierarchical shotgun sequencing strategy. We analyzed genomic sequence using a modification of HPREP (G. Micklem, unpublished data) and screened for repeat elements in RepBase using REPEATMASKER and for matches in human, rodent, EST, STS and other DNA databases. We screened SWISSPROT, TREMBL and TREM-BLNEW peptide databases using BLASTX for homologs to transcripts of unknown function. We screened for CpG islands using CPG, transcription factor elements and putative promoter regions using PROMOTERSCAN and exon predictions using GRAIL, GENSCAN, GENEPARSER and MZEF. We collated annotations using ACeDB. We identified known genes using BLASTN against the EMBL DNA database. Putative roles for remaining transcripts were established using PSI-BLAST and SMART.
IMAGE clone sequence and extension. We obtained IMAGE clones mapping to the region from Research Genetics and sequenced them on a 377 DNA sequencer using ABI Prism Big Dye Terminator (PE Applied Biosystems). We aligned consensus sequences for each IMAGE clone by the GCG program. We obtained Marathon-Ready cDNA RACE libraries from CLONTECH to extend 5′ and 3′ cDNA ends of the IMAGE clones. We designed two gene-specific primers for each direction for each consensus. We cut distinct bands from RACE PCR from gels and purified them. We cloned the bands with ZERO Blunt PCR Cloning kit (Invitrogen). We sequenced the inserts using Big Dye Terminator and integrated them into consensus sequences with GCG.
Tissue expression and splice variation. We obtained Human Multiple Tissue Northern (MTN) Blots and Human Immune System MTN blots from CLON-TECH. We used Human Multiple Tissue, Human Immune System and Human Blood Fractions Multiple Tissues cDNA Panels from CLONTECH for expression analysis by PCR amplification of target sequences. We systematically investigated the exonic and intronic structure of the splice variants of PHF11 by selective PCR, gel separation of products, cloning with ZERO Blunt PCR Cloning kit and Big Dye Terminator sequencing.
Accession numbers. PHF11 and related transcripts are contained in UniGene cluster 279799. Alternative first exons for PHF11 are observed in EMBL sequences AF155105, AL552215, BI463029 and BG759124. cDNA variants that show skipping of PHF11 exon II include ESTHUM accession numbers BF662927 and BE787177 and EMBL accession number AL552215.
